-
From Admission to Discharge: Understanding the Transplant Patient Journey With German Statutory Health Insurance Claims Data
Sep 9, 2025, 16:22 PM -
A Cross-Sectional Analysis of the Reimbursement Obligation for CAR-T Drugs by Huiminbao Insurances in Mainland China of 2024
Sep 9, 2025, 16:22 PM -
Multi-Country Survey to Explore Clinicians Experiences on a New Imaging Technology for Gastrointestinal Endoscopes and Its Impact on Detection and Resection of Lesions
Sep 9, 2025, 16:22 PM -
From Pilot to Platform: Expanding Generative AI Coauthoring Across Global Value Dossier (GVD) Sections With Proven Quality and Validation
Sep 9, 2025, 16:22 PM -
A Conceptual Paper on Integrating a Pharmacometric Multistate Model With Cost-Effectiveness Analysis for Infectious Diseases Treatment Optimization
Sep 9, 2025, 16:22 PM -
Orphan Drug Approvals in the US and Europe: A 2-Year Comparison
Sep 9, 2025, 16:22 PM -
Global Payer Policies Potentially Impacting Pharma Pricing and Market Access Strategies: A Review of Five Key Trends Shaping Pharma Future
Sep 9, 2025, 16:22 PM -
Cost Of Adverse Events Associates With the Management of Invasive Mold Disease With Isavuconazole Compared With Voriconazole in Spain
Sep 9, 2025, 16:22 PM -
Validation Between Antidepressant Treatment Failure Proxy and PHQ-9 Score in Major Depressive Disorder Using a Linked Insurance Claims and Electronic Health Record Dataset
Sep 9, 2025, 16:22 PM -
Cost Implications of Declining MMR Coverage in England: Modeling NHS Burden and the Value of Catch-Up Vaccination
Sep 9, 2025, 16:22 PM -
Live Attenuated Influenza Vaccination (LAIV) for the Prevention of Influenza Illness in Sweden: A Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Health Economic Analysis of Malnutrition in the Netherlands
Sep 9, 2025, 16:22 PM -
Healthcare Resource Use and Direct Healthcare Costs Associated With Respiratory Syncytial Virus Infections in Individuals Aged 18 Years or Older in Italy: A Retrospective Observational Study
Sep 9, 2025, 16:22 PM -
Investigating the Patient-Relevance of Achieving Blood Phe Thresholds in PKU: Results From an Analysis of the OPAL Study
Sep 9, 2025, 16:22 PM -
Evolution of MRD in Hemato-Oncology Clinical Development
Sep 9, 2025, 16:22 PM -
Design and Early Insights From the Pre-HDBOI Study: A Multicountry Real-World Assessment of the Burden in Pre-Motor Manifest Huntington’s Disease
Sep 9, 2025, 16:22 PM -
Italian Perspective on Rare Disease New Treatments and HTA: Insights From Iptacopan Multidimensional Evaluation in PNH
Sep 9, 2025, 16:22 PM -
Impact of Pharmacist-Led Interventions on Health-Related Quality of Life in Diabetic Patients: Assessment Using EQ-5D Domains and Visual Analog Scale
Sep 9, 2025, 16:22 PM -
How Societal Is Sweden? A Study of Inclusion of Societal Costs in Swedish Reimbursement Decisions
Sep 9, 2025, 16:22 PM -
Metamodels SHAP Analysis: Unearthing Data Interactions
Sep 9, 2025, 16:22 PM
